Enhancing immune responses against HIV-1 DNA vaccine by coinoculating IL-6 expression vector

Journal of Virological Methods

Volumn 136, Issue 1-2, 2006, Pages 1-7

  Jiang, Wenzheng ^a   Jin, Ningyi ^b   Cui, Shufang ^c   Li, Zijian ^b   Zhang, Lishu ^b   Wang, Hongwei ^b   Han, Wenyu ^b  

^a EAST CHINA NORMAL UNIVERSITY   (China)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

DNA vaccine; gag; gp120; HIV 1; IL 6; Immune response

Indexed keywords

ANTIBODY; DNA VACCINE; GAG PROTEIN; GLYCOPROTEIN GP 120; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INTERLEUKIN 6;

ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIGEN ANTIBODY REACTION; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EXPRESSION VECTOR; FEMALE; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOREGULATION; INOCULATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN LYMPHOCYTE; VIRUS STRAIN; WESTERN BLOTTING;

ADJUVANTS, IMMUNOLOGIC; AIDS VACCINES; ANIMALS; ANTIBODIES, VIRAL; CYTOTOXICITY, IMMUNOLOGIC; GENE EXPRESSION; GENE PRODUCTS, GAG; GENETIC VECTORS; HELA CELLS; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; INTERLEUKIN-6; MICE; MICE, INBRED BALB C; RECOMBINATION, GENETIC; TRANSFECTION; VACCINES, DNA;

ANIMALIA; EUKARYOTA; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33745915247     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2006.01.020     Document Type: Article

References (41)

1. Barouch D.H., Santra S., Tenner-Racz K., Racz P., Kuroda M.J., Schmitz J.E., Jackson S.S., Lifton M.A., Freed D.C., Perry H.C., Davies M.E., Shiver J.W., and Letvin N.L. Potent CD4+ T cell responses elicited by a bicistronic HIV-1 DNA vaccine expressing gp120 and GM-CSF. J. Immunol. 168 2 (2002) 562-568
2. Boyer J.D., Ugen K.E., Wang B., Agadjanyan M., Gilbert L., Bagarazzi M.L., Chattergoon M., Frost P., Javadian A., Williams W.V., Refaeli Y., Ciccarelli R.B., McCallus D., Coney L., and Weiner D.B. Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination. Nat. Med. 3 5 (1997) 526-532
3. Burton D.R., Desrosiers R.C., Doms R.W., Koff W.C., Kwong P.D., Moore J.P., Nabel G.J., Sodroski J., Wilson I.A., and Wyatt R.T. HIV vaccine design and the neutralizing antibody problem. Nat. Immunol. 5 3 (2004) 233-236
4. Chow Y.H., Chiang B.L., Lee Y.L., Chi W.K., Lin W.C., Chen Y.T., and Tao M.H. Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes. J. Immunol. 160 3 (1998) 1320-1329
5. Chow Y.H., Huang W.L., Chi W.K., Chu Y.D., and Tao M.H. Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2. J. Virol. 71 1 (1997) 169-178
6. Cohen A.D., Boyer J.D., and Weiner D.B. Modulating the immune response to genetic immunization. FASEB J. 12 15 (1998) 1611-1626
7. Conroy R.M., Widera G., LoBuglio A.F., Fuller J.T., Moore S.E., Barlow D.L., Turner J., Yang N.S., and Curiel D.T. Selected strategies to augment polynucleotide immunization. Gene Ther. 3 1 (1996) 67-74
8. Deml L., Bojak A., Steck S., Graf M., Wild J., Schirmbeck R., Wolf H., and Wagner R. Multiple effects of condon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 Gag protein. J. Virol. 75 22 (2001) 10991-11001
9. Donnelly J.J., Ulmer J.B., and Liu M.A. DNA vaccines. Life Sci. 60 3 (1997) 163-172
10. Durali D., Morvan J., Letourneur F., Schmitt D., Guegan N., Dalod M., Saragosti S., Sicard D., Levy J.P., and Gomard E. Cross-reactions between the cytotoxic T-lymphocyte responses of human immunodeficiency virus-infected African and European patients. J. Virol. 72 5 (1998) 3547-3553
11. Feltquate D.M., Hean S., Webster R.G., and Robinson H.L. Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. J. Immunol. 158 5 (1997) 2278-2284
12. Fuller D.H., Corb M.M., Barnett S., Steimer K., and Haynes J.R. Enhancement of immunodeficiency virus-specific immune responses in DNA-immunized rhesus macaques. Vaccine 15 8 (1997) 924-926
13. Geissler M., Gesien A., Tokushige K., and Wands J.R. Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids. J. Immunol. 158 3 (1997) 1231-1237
14. Gorse G.J., Frey S.E., Patel G., Newman F.K., and Belshe R.B. Vaccine-induced antibodies to native and recombinant human immunodeficiency virus type 1 envelope glycoproteins. Vaccine 12 10 (1994) 912-918
15. Gurunathan S., Klinman D.M., and Seder R.A. DNA vaccines: immunology, application, and optimization. Annu. Rev. Immunol. 18 (2000) 927-974
16. Henke A., Chiang C.S., Zell R., and Stelzner A. Co-expression of interleukin-2 to increase the efficacy of DNA vaccine-mediated protection in coxsackievirus B3-infected mice. Antiviral. Res. 64 2 (2004) 131-136
17. Holmgren J., Czerkinsky C., Lycke N., and Svennerholm A.M. Mucosal immunity: implications for vaccine development. Immunobiology 184 2/3 (1992) 157-179
18. Hosie M.J., Flynn J.N., Rigby M.A., Cannon C., Dunsford T., Mackay N.A., Argyle D., Willett B.J., Miyazawa T., Onions D.E., Jarrett O., and Neil J.C. DNA vaccination affords significant protection against feline immunodeficiency virus infection without inducing detectable antiviral antibodies. J. Virol. 72 9 (1998) 7310-7319
19. Iwasaki A., Stiernholm B.J.N., Chan A.K., Berinstein N.L., and Barber B.H. Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines. J. Immunol. 158 10 (1997) 4591-4601
20. Jiang W., Jin N., Cui S., Li Z., Zhang L., Zhang H., Wang H., and Han W. Construction and characterization of recombinant fowlpox virus coexpressing HIV-1(CN) gp120 and IL-2. J. Virol. Methods 130 1/2 (2005) 95-101
21. Jiang W.Z., Jin N.Y., Li Z.J., Zhang L.S., Wang H., and Jin H.T. Construction and identification of recombinant fowlpox virus of coexpressing HIV-1(CN) gp120 and hIL-6. Chinese J. Microbiol. Immunol. 23 6 (2003) 414-417
22. Jiang W.Z., Jin N.Y., Li Z.J., Zhang L.S., Wang H.W., Zhang Y.J., and Han W.Y. Expression and characterization of Gag protein of HIV-1CN in Pichia pastoris. J. Virol. Methods 123 1 (2005) 35-40
23. Kim J.J., Yang J.S., Dang K., Manson K.H., and Weiner D.B. Engineering enhancement of immune responses to DNA-based vaccines in a prostate cancer model in rhesus macquaques through the use of cytokine gene adjuvants. Clin. Cancer Res. 7 Suppl. 3 (2001) 882s-889s
24. Kim J.J., Trivedi N.N., Nottingham L.K., Morrison L., Tsai A., Hu Y., Mahalingam S., Dang K., Ahn L., Doyle N.K., Wilson D.M., Chattergoon M.A., Chalian A.A., Boyer J.D., Agadjanyan M.G., and Weiner D.B. Modulation of amplitude and direction of in vivo immune responses by co-administration of cytokine gene expression cassettes with DNA immunogens. Eur. J. Immunol. 28 3 (1998) 1089-1103
25. Letvin N.L., Montefiori D.C., Yasutomi Y., Perry H.C., Davies M.E., Lekutis C., Alroy M., Freed D.C., Lord C.I., Handt L.K., Liu M.A., and Shiver J.W. Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination. Proc. Natl. Acad. Sci. U.S.A. 94 17 (1997) 9378-9383
26. Letvin N.L., and Walker B.D. Immunopathogenesis and immunotherapy in AIDS virus infections. Nat. Med. 9 7 (2003) 861-866
27. Leung L., Srivastava I.K., Kan E., Legg H., Sun Y., Greer C., Montefiori D.C., zur Megede J., and Barnett S.W. Immunogenicity of HIV-1 Env and Gag in baboons using a DNA prime/protein boost regimen. AIDS 18 7 (2004) 991-1001
28. McAdam S., Kaleebu P., Krausa P., Goulder P., French N., Collin B., Blanchard T., Whitworth J., McMichael A., and Gotch F. Cross-clade recognition of p55 by cytotoxic T lymphocytes in HIV-1 infection. AIDS 12 6 (1998) 571-579
29. Okada E., Sasaki S., Ishii N., Aoki I., Yasuda T., Nishioka K., Fukushima J., Miyazaki J.I., Wahren B., and Okuda K. Intranasal immunization of a DNA vaccine with IL-12-and granulocyte-macrophage colony-stimulating factor (GM-CSF)-expressing plasmids in liposomes induces strong mucosal and cell-mediated immune responses against HIV-1 antigens. J. Immunol. 159 7 (1997) 3638-3647
30. Pertmer T.M., Eisenbraun M.D., McCabe D., Prayaga S.K., Fuller D.H., and Haynes J.R. Gene gun-based nucleic acid immunization: elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA. Vaccine 13 15 (1995) 1427-1430
31. Ramsay A.J., Husband A.J., Ramshaw I.A., Bao S., Matthaei K.I., Koehler G., and Kopf M. The role of interleukin-6 in mucosal IgA antibody responses in vivo. Science 264 5158 (1994) 561-563
32. Raz E., Watanabe A., Baird S.M., Eisenberg R.A., Parr T.B., Lotz M., Kipps T.J., and Carson D.A. Systemic immunological effects of cytokine genes injected into skeletal muscle. Proc. Natl. Acad. Sci. U.S.A. 90 10 (1993) 4523-4527
33. Sambrook J., Fritsch E.F., and Maniatis T. Molecular Cloning: A Laboratoty Manual. 2nd Ed. (1989), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York pp. 880-897
34. Scandella C.J., Kilpatrick J., Lidster W., Parker C., Moore J.P., Moore G.K., Mann K.A., Brown P., Coates S., Chapman B., Masiarz R.R., Steimer K.S., and Haigwood N.L. Non-affinity purification of recombinant gp120 for use in AIDS vaccine development. AIDS Res. Hum. Retroviruses 9 12 (1993) 1233-1244
35. Song K., Chang Y., and Prud'homme G.J. Regulation of T-helper-1 versus T-helper-2 activity and enhancement of tumor immunity by combined DNA-based vaccination and nonviral cytokine gene transfer. Gene Ther. 7 6 (2000) 481-492
36. Tsuji T., Hamajima K., Fukushima J., Xin K.Q., Ishii N., Aoki I., Ishigatsubo Y., Tani K., Kawamoto S., Nitta Y., Miyazaki J., Koff W.C., Okubo T., and Okuda K. Enhancement of cell-mediated immunity against HIV-1 induced by coinoculation of plasmid-encoded HIV-1 antigen with plasmid expressing IL-12. J. Immunol. 158 8 (1997) 4008-4013
37. Ugen K.E., Boyer J.D., Wang B., Bagarazzi M., Javadian A., Frost P., Merva M.M., Agadjanyan M.G., Nyland S., Williams W.V., Coney L., Ciccarelli R., and Weiner D.B. Nucleic acid immunization of chimpanzees as a prophylactic/immunotherapeutic vaccination model for HIV-1: prelude to a clinical trial. Vaccine 15 8 (1997) 927-930
38. Van Snick J. Interleukin-6: an overview. Annu. Rev. Immunol. 8 (1990) 253-278
39. Wei X., Decker J.M., Wang S., Hui H., Kappes J.C., Wu X., Salazar-Gonzalez J.F., Salazar M.G., Kilby J.M., Saag M.S., Komarova N.L., Nowak M.A., Hahn B.H., Kwong P.D., and Shaw G.M. Antibody neutralization and escape by HIV-1. Nature 422 6929 (2003) 307-312
40. Wyatt R., and Sodroski J. The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. Science 280 5371 (1998) 1884-1888
41. Xiang Z., and Ertl H.C.J. Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines. Immunity 2 2 (1995) 129-135